Cancer and the chemokine network

Inflammation and cancer

Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111

Stem cells, cancer, and cancer stem cells

Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738

Inflammation and cancer: back to Virchow?

Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528

Involvement of chemokine receptors in breast cancer metastasis

Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340

Chemokines

Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923

Tumour-educated macrophages promote tumour progression and metastasis

Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413

Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397

A multigenic program mediating breast cancer metastasis to bone

Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605

Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice

Hata, R., Izukuri, K., Kato, Y., Sasaki, S., Mukaida, N., Maehata, Y., Miyamoto, C., Akasaka, T., Yang, X., Nagashima, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep09083 · Cited by 46

CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5

Pham, K., Luo, D., Liu, C., & Harrison, J. K. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.009 · Cited by 46

Inflammation, Tumor Necrosis Factor and Wnt Promotion in Gastric Cancer Development

Oguma, K., Oshima, H., & Oshima, M. (2010) · Future Oncology · doi:10.2217/fon.10.13 · Cited by 46

Tumor associated macrophage: a review on the phenotypes, traits and functions.

Ramanathan, S., & Jagannathan, N. (2014) · Europe PMC (PubMed Central) · Cited by 46

CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer

Bai, M., Chen, X., & Ba, Y. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.665 · Cited by 46

Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma

Ren, Z., Liang, S., Yang, J., Han, X., Shan, L., Wang, B., Mu, T., Zhang, Y., Yang, X., Xiong, S., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4352-8 · Cited by 48

Tocotrienol and cancer metastasis

de Silva, L. S., Chuah, L., Meganathan, P., & Fu, J. (2016) · BioFactors · doi:10.1002/biof.1259 · Cited by 46

Oligonucleotide-Based Theranostic Nanoparticles in Cancer Therapy

Shahbazi, R., Özpolat, B., & Ulubayram, K. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0035 · Cited by 46

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

Suenaga, M., Mashima, T., Kawata, N., Wakatsuki, T., Horiike, Y., Matsusaka, S., Dan, S., Shinozaki, E., Seimiya, H., Mizunuma, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9187 · Cited by 47

Understanding cancer complexome using networks, spectral graph theory and multilayer framework

Rai, A., Pradhan, P., Nagraj, J., Lohitesh, K., Chowdhury, R., & Jalan, S. (2017) · Scientific Reports · doi:10.1038/srep41676 · Cited by 48

Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers

Herrera-Martínez, A. D., Hofland, L. J., Moreno, M. Á. G., Castano, J. P., de Herder, W. W., & Feelders, R. A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0354 · Cited by 47

The Network of Cytokines in Brain Metastases

Fares, J., Cordero, Á., Kanojia, D., & Lesniak, M. S. (2021) · Cancers · doi:10.3390/cancers13010142 · Cited by 46

Involvement of CXCL12 and CXCR4 in Lymph Node Metastases and Development of Oral Squamous Cell Carcinomas

Oliveira-Neto, H. H., Silva, É. T., Leles, C. R., a, E. F. M. C., Alencar, R. D. C. G., Silva, T. A., & Batista, A. C. (2008) · Tumor Biology · doi:10.1159/000152944 · Cited by 46

Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases

Lee, C., Kakinuma, T., Wang, J., Zhang, H., Palmer, D. C., Restifo, N. P., & Hwang, S. T. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0310 · Cited by 46

Function of Liver Activation-Regulated Chemokine/CC Chemokine Ligand 20 Is Differently Affected by Cathepsin B and Cathepsin D Processing

Hasan, L., Mazzucchelli, L., Liebi, M., Lis, M., Hunger, R. E., Tester, A. M., Overall, C. M., & Wolf, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6512 · Cited by 46

CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

Bao, S., Darvishi, M., Amin, A. H., Al-Haideri, M. T., Patra, I., Kashikova, K., Ahmad, I., Alsaikhan, F., Al‐qaim, Z. H., Al-Gazally, M. E., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04444-w · Cited by 46

Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms

Kaemmerer, D., Reimann, C., Specht, E., Wirtz, R. M., Sayeg, M., Baum, R. P., Schulz, S., & Lupp, A. (2014) · Oncotarget · doi:10.18632/oncotarget.3242 · Cited by 45

Review on Molecular and Chemopreventive Potential of Nimbolide in Cancer

Perumal, E., & Arunakaran, J. (2014) · Genomics & Informatics · doi:10.5808/gi.2014.12.4.156 · Cited by 45

Leukocyte Infiltration in Cancer Creates an Unfavorable Environment for Antitumor Immune Responses: A Novel Target for Therapeutic Intervention

Bronte, V., Cingarlini, S., Marigo, I., Santo, C. D., Gallina, G., Dolcetti, L., Ugel, S., Peranzoni, E., Mandruzzato, S., & Zanovello, P. (2006) · Immunological Investigations · doi:10.1080/08820130600754994 · Cited by 45

Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma

Baumhoer, D., Smida, J., Zillmer, S., Rosemann, M., Atkinson, M. J., Nelson, P. J., Jundt, G., von Luettichau, I., & Nathrath, M. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.193 · Cited by 45

What fires prometheus?

Viebahn, C. S., & Yeoh, G. C. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.025 · Cited by 46

CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis

Yasuoka, H., Kodama, R., Hirokawa, M., Takamura, Y., Miyauchi, A., Sanke, T., & Nakamura, Y. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-274 · Cited by 45

Temozolomide-induced modification of the CXC chemokine network in experimental gliomas

Kiss (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.964 · Cited by 45

The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease

Berghuis, D., Schilham, M. W., Santos, S. J., Savola, S. P., Knowles, H. J., Dirksen, U., Schaefer, K., Vakkila, J., Hogendoorn, P. C. W., & Lankester, A. C. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-24 · Cited by 46

The Lymphotactin Receptor Is Expressed in Epithelial Ovarian Carcinoma and Contributes to Cell Migration and Proliferation

Kim, M., Rooper, L. M., Xie, J., Rayahin, J., Burdette, J. E., Kajdacsy‐Balla, A., & Barbolina, M. V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0361 · Cited by 45

Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy

Jiang, K., Li, J., Yin, J., Ma, Q., Yan, B., Zhang, X., Wang, L., Wang, L., Liu, T., Zhang, Y., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.030 · Cited by 46

Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types

Budczies, J., Denkert, C., Győrffy, B., Schirmacher, P., & Stenzinger, A. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0308-8 · Cited by 45

Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists

Szpakowska, M., Meyrath, M., Reynders, N., Counson, M., Hanson, J., Steyaert, J., & Chevigné, A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.007 · Cited by 44

Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy

Takacs, G. P., Flores‐Toro, J., & Harrison, J. K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107790 · Cited by 47

Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2

Yu, Y., & Xiaoyan, X. (2007) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000236259.88146.a4 · Cited by 45

Chemokine sequestration by atypical chemokine receptors

Hansell, C. A. H., Simpson, C. V., & Nibbs, R. J. B. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341009 · Cited by 45

Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management

Allemailem, K. S., Alsahli, M. A., Almatroudi, A., Alrumaihi, F., Abdulmonem, W. A., Moawad, A. A., Alwanian, W. M., Almansour, N. M., Rahmani, A. H., & Khan, A. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s424872 · Cited by 49

The Biology of Metastases in Pediatric Sarcomas

Krishnan, K., Khanna, C., & Helman, L. J. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00006 · Cited by 44

Characterization and expression of the CXCR1 and CXCR4 in miiuy croaker and evolutionary analysis shows the strong positive selection pressures imposed in mammal CXCR1

Xu, T., Zhu, Z., Sun, Y., Ren, L., & Wang, R. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.12.006 · Cited by 44

Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin

Mei, L., Liu, Y., Zhang, Q., Gao, H., Zhang, Z., & He, Q. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.017 · Cited by 44

Down-Regulation of CXCL12 by DNA Hypermethylation and Its Involvement in Gastric Cancer Metastatic Progression

Yu, Z. H., Chen, J., Zhang, S., Chang, X., Ma, J., & Dai, D. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1922-5 · Cited by 44

Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal Mice

Du, H., Zhao, T., Ding, X., & Yan, C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.05.021 · Cited by 44

Role of the CXCL12–CXCR4 axis in the development of deep rectal endometriosis

Leconte, M., Chouzenoux, S., Nicco, C., Chéreau, C., Arkwright, S., Santulli, P., Weill, B. J., Chapron, C., Dousset, B. E., & Batteux, F. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.12.121 · Cited by 45

Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women

Tabung, F. K., Steck, S. E., Liese, A. D., Zhang, J., Ma, Y., Johnson, K., Lane, D. S., Qi, L., Snetselaar, L., Vitolins, M. Z., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3925-6 · Cited by 43

DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis

Zhang, Y., Zhang, Q., Zhang, M., Yuan, M., Wang, Z., Zhang, J., Zhou, X., Zhang, Y., Lin, F., Na, H., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0639-2 · Cited by 44

CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells

Wang, M., Lin, T., Wang, Y., Gao, S., Yang, Z., Hong, X., & Chen, G. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s133055 · Cited by 44

The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance

Prete, A. D., Sozio, F., Schioppa, T., Ponzetta, A., Vermi, W., Calza, S., Bugatti, M., Salvi, V., Bernardini, G., Benvenuti, F., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0168 · Cited by 45

Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis

Stephens, B. S., Ngo, T., Kufareva, I., & Handel, T. M. (2020) · Science Signaling · doi:10.1126/scisignal.aay5024 · Cited by 44

The Role of microRNAs in Epithelial Ovarian Cancer Metastasis

Nguyen, V. H. L., Yue, C., Du, K. Y., Salem, M., O’Brien, J. A., & Peng, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197093 · Cited by 43

Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response

Du, X., Hou, Y., Huang, J., Pang, Y., Ruan, C., Wu, W., Xu, C., Zhang, H., Yin, L., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.014 · Cited by 45

Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells

Tyagi, T., Jain, K., Yarovinsky, T. O., Chiorazzi, M., Du, J., Castro, C., Griffin, J. L., Korde, A., Martin, K. A., Takyar, S. S., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212218 · Cited by 45

CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro

Koizumi, K., Kozawa, Y., Ohashi, Y., Nakamura, E. S., Aozuka, Y., Sakurai, H., Ichiki, K., Doki, Y., Misaki, T., & Saiki, I. (2007) · Oncology Reports · doi:10.3892/or.17.6.1511 · Cited by 44

Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells

Sanna, E., Miotti, S., Mazzi, M., Santis, G. D., Canevari, S., & Tomassetti, A. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.005 · Cited by 44

Host Cxcr2-dependent regulation of mammary tumor growth and metastasis

Sharma, B., Nannuru, K. C., Varney, M. L., & Singh, R. K. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9691-0 · Cited by 45

The regulatory network of the chemokine CCL5 in colorectal cancer

Zhang, X., Zhang, X., Wang, Y., Fang, Y., Li, M., Liu, X., Luo, H.-Y., & Tian, Y. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2205168 · Cited by 42

Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis

Huang, Y. V., Sun, Y., Chou, H., Wagner, N., Vitale, M. R., Bayer, A. L., Xu, B., Lee, D. C., Lin, Z., Branche, C., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325652 · Cited by 51

A Critical Role of Gβγ in Tumorigenesis and Metastasis of Breast Cancer

Tang, X., Sun, Z., Runne, C., Madsen, J., Domann, F. E., Henry, M. D., Lin, F. H., & Chen, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206615 · Cited by 43

Loss of RUNX3 expression promotes cancer‐associated bone destruction by regulating CCL5 , CCL19 and CXCL11 in non‐small cell lung cancer

Kim, H., Park, J., Lee, S., Kim, K., Park, K.-K., & Chung, W. (2015) · The Journal of Pathology · doi:10.1002/path.4597 · Cited by 41

Control of the blood–brain barrier function in cancer cell metastasis

Blecharz, K., Colla, R., Rohde, V., & Vajkoczy, P. (2015) · Biology of the Cell · doi:10.1111/boc.201500011 · Cited by 43

The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination

Erreni, M., Siddiqui, I., Marelli, G., Grizzi, F., Bianchi, P. P., Morone, D., Marchesi, F., Celesti, G., Pesce, S., Doni, A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501335 · Cited by 43

Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms

Dondeti, M. F., El‐maadawy, E. A., & Talaat, R. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6800 · Cited by 43

The Role of Chemokines in Thyroid Carcinoma

Yapa, S., Mulla, O., Green, V., England, J. A., & Greenman, J. (2017) · Thyroid · doi:10.1089/thy.2016.0660 · Cited by 43

Microfluidic-Based Immunomodulation of Immune Cells Using Upconversion Nanoparticles in Simulated Blood Vessel–Tumor System

Wimalachandra, D., Li, Y., Liu, J., Shikha, S., Zhang, J., Lim, Y., & Zhang, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15178 · Cited by 43

Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice

de Souza, C. M., de Carvalho, L. F., Vieira, T. D. S., Silva, A. C. A. E., Lopes, M. T. P., Ferreira, M. A. N. D., Andrade, S. P., & Cassali, G. D. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.04.005 · Cited by 43

Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation

Alfaro, C., Suárez, N., Martínez‐Forero, I., Palazón, A., Rouzaut, A., Solano, S., Feijoó, E., Gúrpide, A., Bolaños, E., Erro, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017922 · Cited by 46

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws

Gadaleta, E., Cutts, R. J., Kelly, G. P., Crnogorac‐Jurcevic, T., Kocher, H. M., Lemoine, N. R., & Chelala, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr533 · Cited by 43

Molecular mechanisms of metastasis

Hoon, D. S. �., Ferris, R. L., Tanaka, R., Chong, K. K., Alix‐Panabières, C., & Pantel, K. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21690 · Cited by 42

Chemokines in the Melanoma Metastasis Biomarkers Portrait

Neagu, M. T., Constantin, C., & Longo, C. (2015) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2015.1035593 · Cited by 42

An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice

Daubeuf, F., Hachet‐Haas, M., Gizzi, P., Gasparik, V., Bonnet, D., Utard, V., Hibert, M., Frossard, N., & Galzi, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.449348 · Cited by 42

Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer

Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-172 · Cited by 42

ERK-Dependent Downregulation of the Atypical Chemokine Receptor D6 Drives Tumor Aggressiveness in Kaposi Sarcoma

Savino, B., Caronni, N., Anselmo, A., Pasqualini, F., Borroni, E. M., Basso, G., Celesti, G., Laghi, L., Tourlaki, A., Boneschi, V., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0202 · Cited by 44

Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness

Xie, Y., Wang, Y., Li, J., Yu, H., Jaramillo, L., Wehrkamp, C. J., Phillippi, M. A., Mohr, A. M., Chen, Y., Talmon, G. A., et al. (2018) · Theranostics · doi:10.7150/thno.26506 · Cited by 42

A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells

Sbrissa, D., Semaan, L., Govindarajan, B., 李彦锋, Carruthers, N. J., Stemmer, P. M., Cher, M. L., Sethi, S. N., Vaishampayan, U. N., Shisheva, A., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0448-0 · Cited by 41

Complement inhibitor factor H expressed by breast cancer cells differentiates CD14 + human monocytes into immunosuppressive macrophages

Smoląg, K. I., Mueni, C. M., Leandersson, K., Jirström, K., Hagerling, C., Mörgelin, M., Barlow, P. N., Martin, M., & Blom, A. M. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1731135 · Cited by 42

Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins

Galland, S., Martin, P., Fregni, G., Letovanec, I., & Stamenkovic, I. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.005 · Cited by 43

Autophagy-Dependent Apoptosis Induced by Apoferritin–Cu(II) Nanoparticles in Multidrug-Resistant Colon Cancer Cells

Xiong, K., Zhou, Y., Karges, J., Du, K., Shen, J., Lin, M., Wei, F., Kou, J., Chen, Y., Ji, L., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c07223 · Cited by 42

Simultaneous blockade of VEGFR‐1 and VEGFR‐2 activation is necessary to efficiently inhibit experimental melanoma growth and metastasis formation

Gille, J., Heidenreich, R., Pinter, A., Schmitz, J., Boehme, B., Hicklin, D. J., Henschler, R., & Breier, G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22531 · Cited by 42

Anti-leukemic activity of Lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

Sutherland, M. K., Yu, C., Lewis, T. S., Miyamoto, J. B., Morris-Tilden, C. A., Jonas, M., Sutherland, J., Nesterova, A., Gerber, H., Sievers, E. L., et al. (2009) · mAbs · doi:10.4161/mabs.1.5.9288 · Cited by 42

Human B cells express the orphan chemokine receptor CRAM‐A/B in a maturation‐stage‐dependent and CCL5‐modulated manner

Hartmann, T. N., Leick, M., Ewers, S., Diefenbacher, A., Schraufstätter, I. U., Honczarenko, M., & Burger, M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02836.x · Cited by 43

Chemokine‐derived peptides as carriers for gene delivery to CXCR4 expressing cells

Egorova, A., Kiselev, A., Häkli, M., Ruponen, M., Баранов, В. С., & Urtti, A. O. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1366 · Cited by 42

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma

Wang, Z., Xie, H., Zhou, L., Liu, Z., Fu, H., Zhu, Y., Xu, L., & Xu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10492 · Cited by 43

Tumour-immune cell interactions modulated by chemokines

Jöhrer, K., Pleyer, L., Olivier, A., Maizner, E., Zelle‐Rieser, C., & Greil, R. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.3.269 · Cited by 41

Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging

Aghanejad, A., Jalilian, A. R., Fazaeli, Y., Beiki, D., Fateh, B., & Khalaj, A. (2013) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-013-2822-2 · Cited by 41

The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis

Zhao, B., Cui, K., Wang, C.-L., Wang, A., Zhang, B., Zhou, W., Zhao, W., & Li, S. (2011) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-011-0395-4 · Cited by 41

Endogenous latent membrane protein 1 in Epstein–Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines

Lai, H.-C., Hsiao, J., Chen, C.-W., Wu, S.-Y., Lee, C.-H., Su, I., Takada, K., & Chang, Y. (2010) · Virology · doi:10.1016/j.virol.2010.06.037 · Cited by 41

Clinical utilization of chemokines to combat cancer: the double-edged sword

Dell’Agnola, C., & Biragyn, A. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.267 · Cited by 46

The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis

Yan, R., Shuai, H., Luo, X., Wang, X., & Guan, B. (2017) · Bioscience Reports · doi:10.1042/bsr20171021 · Cited by 41

CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression

Mandal, P. K., Biswas, S., Mandal, G., Purohit, S., Gupta, A., Majumdar, A., Chowdhury, S. R., & Bhattacharyya, A. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.031 · Cited by 41

A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS -Mutant Colon Cancer Cells

Inoue, A., Mizushima, T., Wu, X., Okuzaki, D., Kambara, N., Ishikawa, S., Wang, J., Qian, Y., Hirose, H., Yokoyama, Y., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0850 · Cited by 41

Acetyl- l -carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways

Baci, D., Bruno, A., Bassani, B., Tramacere, M., Mortara, L., Albini, A., & Noonan, D. M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.018 · Cited by 40

Oesophageal squamous cell carcinoma–associated IL‐33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase

Mai, S., Liu, L., Jiang, J., Ren, P., Diao, D., Wang, H., & Cai, K. (2020) · Cell Proliferation · doi:10.1111/cpr.12960 · Cited by 41

CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway

Chen, B., Song, L., Nie, X., Lin, F., Yu, Z., Kong, W., Qi, X., & Wang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.577229 · Cited by 41

The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells

Ocaña, E., Delgado-Pérez, L. A., Campos‐Caro, A., Munoz, J., Paz, A., Franco, R., & Brieva, J. A. (2007) · Haematologica · doi:10.3324/haematol.10649 · Cited by 41

Synthesis and Evaluation of [67Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4

Aghanejad, A. (2014) · Scientia Pharmaceutica · doi:10.3797/scipharm.1305-18 · Cited by 41

Inhibition of Chemokine Receptor Expression on Uveal Melanomas by CXCR4 siRNA and Its Effect on Uveal Melanoma Liver Metastases

Li, H., Yang, W., Chen, P. W., ALIZADEH, H. M., & Niederkorn, J. Y. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3804 · Cited by 41

Keeping Out the Bad Guys: Gateway to Cellular Target Therapy

Kitamura, T., & Taketo, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2100 · Cited by 41

Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer

Wei, L., Cao, S., Yu, W., Liu, Y., & Wang, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3645 · Cited by 42

Oral administration of PCBs induces proinflammatory and prometastatic responses

Sipka, S., Eum, S. Y., Son, K. W., Xu, S., Gavalas, V., Hennig, B., & Toborek, M. J. (2007) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2007.10.020 · Cited by 40

β-Catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer

Wang, Z., & Ma, Q. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.01.069 · Cited by 40

Identification of Ghrelin Receptor Blocker, D-[Lys3] GHRP-6 as a CXCR4 Receptor Antagonist

Patel, K. G., Dixit, V. D., Lee, J. H., Kim, J. W., Schaffer, E. M., Nguyen, D., & Taub, D. D. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.8.108 · Cited by 40

CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis

Huang, A.-F., Chen, M.-W., Huang, S.-M., Kao, C.-L., Lai, H., & Chan, J. Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-115 · Cited by 42

Hijacking GPCRs by viral pathogens and tumor

Zhang, J., Feng, H., Xu, S., & Feng, P. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.021 · Cited by 39

Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9

Baek, S. H., Kim, S., Nam, D., Lee, J., Ahn, K. S., Choi, S., Kim, S., Shim, B. S., Chang, I., & Ahn, K. S. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.664151 · Cited by 40

CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma

Werner, T. A., Förster, C., Dizdar, L., Verde, P. E., Raba, K., Schott, M., Knoefel, W. T., & Krieg, A. H. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.364 · Cited by 40

Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer

Divella, R., Daniele, A., Luca, R. D., Simone, M. D., Naglieri, E., Savino, E., Abbate, I., Gadaleta, C. D., & Ranieri, G. (2017) · Anticancer Research · doi:10.21873/anticanres.11895 · Cited by 40

Chemokine biology in cancer

Balkwill, F. R. (2002) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00127-6 · Cited by 238

Manipulating the chemokine‐chemokine receptor network to treat cancer

Ruffini, P. A., Morandi, P., Cabıoğlu, N., Altundağ, K., & Cristofanilli, M. (2007) · Cancer · doi:10.1002/cncr.22706 · Cited by 114

Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment

O’Hayre, M., Salanga, C. L., Handel, T. M., & Allen, S. J. (2008) · Biochemical Journal · doi:10.1042/bj20071493 · Cited by 303

Chemokines and Metastasis

Nannuru, K. C., Singh, S., & Singh, R. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_27 · Cited by 7

Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization

Marcuzzi, E., Angioni, R., Molon, B., & Calì, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010096 · Cited by 162